Sterile reconstitution solution in 3 mL, 10 mL and 30 mL vials
Browse related peptide guides Semax Peptide UK Review a different seven-residue research peptide associated with neurological research
BPC-157, TB-500, CJC-1295, and ipamorelin are not approved for human clinical use, and their use poses significant health risks for athletes
The numbers below assume the standard research-planning band of about 250 mcg twice daily from 10 mg vials reconstituted with 2 mL bacteriostatic water
Cancer 131 , 25472552 (2012)
According to the MHRA-approved product information, the most common side effects include: Nausea particularly during the initial weeks of treatment or following dose escalation Vomiting often transient and improves with continued use Diarrhoea commonly reported in clinical trials Constipation less common but reported in some individuals Abdominal pain or discomfort typically mild to moderate in severity These gastrointestinal symptoms are usually most pronounced when starting Ozempic or increasing the dose, and they tend to diminish over time as the body adjusts to the medication